MacroGenics reported $12.53M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
AbbVie USD 12.48B 1.56B Mar/2025
Amgen USD 8.7B 569M Jun/2025
AstraZeneca USD 16.24B 1.42B Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
Bristol-Myers Squibb USD 15.1B 515M Jun/2025
Daiichi Sankyo JPY 611.76B 7.34B Jun/2025
Eli Lilly USD 17.21B 3.2B Jun/2025
Genmab DKK 998M 199M Jun/2025
Geron USD 39.36M 5.38M Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
J&J USD 16.02B 1.18B Mar/2025
MacroGenics USD 12.53M 8.22M Jun/2025
Merck USD 12.72B 1.14B Jun/2025
Pfizer USD 16.09B 1.35B Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
Xencor USD 47.55M 9.77M Jun/2025